5-Fluorouracil modulation in colorectal carcinoma experience of German investigators

Adv Exp Med Biol. 1993:339:99-107. doi: 10.1007/978-1-4615-2488-5_11.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • Fluorouracil / administration & dosage
  • Germany
  • Humans
  • Immunologic Factors / therapeutic use*
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Leucovorin / administration & dosage
  • Recombinant Proteins

Substances

  • Antineoplastic Agents
  • Immunologic Factors
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Leucovorin
  • Fluorouracil